Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A beta amyloidogenesis: unique, or variation on a systemic theme?

R Kisilevsky1, P E Fraser

  • 1Department of Pathology, Queen's University, Kingston, Ontario Canada.

Critical Reviews in Biochemistry and Molecular Biology
|January 1, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Extracellular Tau Oligomers Produce An Immediate Impairment of LTP and Memory.

Scientific reports·2016
Same author

Islet amyloid inhibitors improve glucose homeostasis in a transgenic mouse model of type 2 diabetes.

Diabetes, obesity & metabolism·2015
Same author

Amyloid and the cardiovascular system: A review of pathogenesis and pathology with clinical correlations.

Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology·2015
Same author

Amyloid formation in human islets is enhanced by heparin and inhibited by heparinase.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2015
Same author

Current and future implications of basic and translational research on amyloid-β peptide production and removal pathways.

Molecular and cellular neurosciences·2015
Same author

Altered brain development in an early-onset murine model of Alzheimer's disease.

Neurobiology of aging·2014

Amyloid is a complex protein deposit involved in millions of diseases, including Alzheimer's. Understanding its structure and formation is key to developing new anti-amyloid therapies.

Area of Science:

  • Biochemistry
  • Pathology
  • Molecular Biology

Background:

  • Amyloid was historically viewed as a minor pathological finding.
  • Recent understanding reveals amyloid is a complex in vivo process involving disease-specific proteins and common structural components.
  • Amyloid deposition is implicated in millions of patient diseases, including Alzheimer's disease and diabetes.

Purpose of the Study:

  • To review the current definition and classification of amyloid.
  • To examine the in vivo pathogenetic events involved in amyloid deposition.
  • To explore potential anti-amyloid therapeutic strategies based on understanding amyloid formation.

Main Methods:

  • Review of existing literature on amyloid definition, classification, and pathogenesis.

Related Experiment Videos

  • Emphasis on beta-amyloid (A beta) and its role in disease.
  • Analysis of factors influencing amyloid fibril formation in vivo.

    • Main Results:

    • Amyloid is not a single entity but a complex organization of proteins.
    • Key factors in amyloid deposition include precursor protein availability, proteolysis, specific amino acid sequences, nucleating particles, and the microenvironment.
    • Common structural components are present in all amyloids and may play a role in accumulation.

    Conclusions:

    • Amyloid formation is a multifactorial process requiring specific conditions and components.
    • Understanding the role of common components and basement membrane association is crucial for therapeutic development.
    • Targeting amyloid formation pathways offers potential for novel anti-amyloid therapies.